These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39287133)

  • 1. G-quadruplexes in an SVA retrotransposon cause aberrant TAF1 gene expression in X-linked dystonia parkinsonism.
    Nicoletto G; Terreri M; Maurizio I; Ruggiero E; Cernilogar FM; Vaine CA; Cottini MV; Shcherbakova I; Penney EB; Gallina I; Monchaud D; Bragg DC; Schotta G; Richter SN
    Nucleic Acids Res; 2024 Oct; 52(19):11571-11586. PubMed ID: 39287133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZNF91 is an endogenous repressor of the molecular phenotype associated with X-linked dystonia-parkinsonism (XDP).
    Rosenkrantz JL; Brandorff JE; Raghib S; Kapadia A; Vaine CA; Bragg DC; Farmiloe G; Jacobs FMJ
    Proc Natl Acad Sci U S A; 2024 Aug; 121(33):e2401217121. PubMed ID: 39102544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in
    Bragg DC; Mangkalaphiban K; Vaine CA; Kulkarni NJ; Shin D; Yadav R; Dhakal J; Ton ML; Cheng A; Russo CT; Ang M; Acuña P; Go C; Franceour TN; Multhaupt-Buell T; Ito N; Müller U; Hendriks WT; Breakefield XO; Sharma N; Ozelius LJ
    Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E11020-E11028. PubMed ID: 29229810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells.
    Ito N; Hendriks WT; Dhakal J; Vaine CA; Liu C; Shin D; Shin K; Wakabayashi-Ito N; Dy M; Multhaupt-Buell T; Sharma N; Breakefield XO; Bragg DC
    Dis Model Mech; 2016 Apr; 9(4):451-62. PubMed ID: 26769797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the Causal Mechanism of X-Linked Dystonia-Parkinsonism by Integrating Genome and Transcriptome Assembly.
    Aneichyk T; Hendriks WT; Yadav R; Shin D; Gao D; Vaine CA; Collins RL; Domingo A; Currall B; Stortchevoi A; Multhaupt-Buell T; Penney EB; Cruz L; Dhakal J; Brand H; Hanscom C; Antolik C; Dy M; Ragavendran A; Underwood J; Cantsilieris S; Munson KM; Eichler EE; Acuña P; Go C; Jamora RDG; Rosales RL; Church DM; Williams SR; Garcia S; Klein C; Müller U; Wilhelmsen KC; Timmers HTM; Sapir Y; Wainger BJ; Henderson D; Ito N; Weisenfeld N; Jaffe D; Sharma N; Breakefield XO; Ozelius LJ; Bragg DC; Talkowski ME
    Cell; 2018 Feb; 172(5):897-909.e21. PubMed ID: 29474918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional Alterations in X-Linked Dystonia-Parkinsonism Caused by the SVA Retrotransposon.
    Pozojevic J; Algodon SM; Cruz JN; Trinh J; Brüggemann N; Laß J; Grütz K; Schaake S; Tse R; Yumiceba V; Kruse N; Schulz K; Sreenivasan VKA; Rosales RL; Jamora RDG; Diesta CCE; Matschke J; Glatzel M; Seibler P; Händler K; Rakovic A; Kirchner H; Spielmann M; Kaiser FJ; Klein C; Westenberger A
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SVA insertion in X-linked Dystonia Parkinsonism alters histone H3 acetylation associated with TAF1 gene.
    Petrozziello T; Dios AM; Mueller KA; Vaine CA; Hendriks WT; Glajch KE; Mills AN; Mangkalaphiban K; Penney EB; Ito N; Fernandez-Cerado C; Legarda GPA; Velasco-Andrada MS; Acuña PJ; Ang MA; Muñoz EL; Diesta CCE; Macalintal-Canlas R; Acuña G; Sharma N; Ozelius LJ; Bragg DC; Sadri-Vakili G
    PLoS One; 2020; 15(12):e0243655. PubMed ID: 33315879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mini-heterochromatin domains constrain the cis-regulatory impact of SVA transposons in human brain development and disease.
    Horváth V; Garza R; Jönsson ME; Johansson PA; Adami A; Christoforidou G; Karlsson O; Castilla Vallmanya L; Koutounidou S; Gerdes P; Pandiloski N; Douse CH; Jakobsson J
    Nat Struct Mol Biol; 2024 Oct; 31(10):1543-1556. PubMed ID: 38834915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating Hexanucleotide Repeat Number and Methylation within the X-Linked Dystonia-Parkinsonism (XDP)-Related SVA Retrotransposon in
    Lüth T; Laβ J; Schaake S; Wohlers I; Pozojevic J; Jamora RDG; Rosales RL; Brüggemann N; Saranza G; Diesta CCE; Schlüter K; Tse R; Reyes CJ; Brand M; Busch H; Klein C; Westenberger A; Trinh J
    Genes (Basel); 2022 Jan; 13(1):. PubMed ID: 35052466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonism.
    Westenberger A; Reyes CJ; Saranza G; Dobricic V; Hanssen H; Domingo A; Laabs BH; Schaake S; Pozojevic J; Rakovic A; Grütz K; Begemann K; Walter U; Dressler D; Bauer P; Rolfs A; Münchau A; Kaiser FJ; Ozelius LJ; Jamora RD; Rosales RL; Diesta CCE; Lohmann K; König IR; Brüggemann N; Klein C
    Ann Neurol; 2019 Jun; 85(6):812-822. PubMed ID: 30973967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Glucocorticoids on
    Cruz SED; Bagamasbad P
    J ASEAN Fed Endocr Soc; 2023; 38(1):23-30. PubMed ID: 37234925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome editing in induced pluripotent stem cells rescues TAF1 levels in X-linked dystonia-parkinsonism.
    Rakovic A; Domingo A; Grütz K; Kulikovskaja L; Capetian P; Cowley SA; Lenz I; Brüggemann N; Rosales R; Jamora D; Rolfs A; Seibler P; Westenberger A; König I; Klein C
    Mov Disord; 2018 Jul; 33(7):1108-1118. PubMed ID: 30153385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism.
    Makino S; Kaji R; Ando S; Tomizawa M; Yasuno K; Goto S; Matsumoto S; Tabuena MD; Maranon E; Dantes M; Lee LV; Ogasawara K; Tooyama I; Akatsu H; Nishimura M; Tamiya G
    Am J Hum Genet; 2007 Mar; 80(3):393-406. PubMed ID: 17273961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing.
    Tshilenge KT; Bons J; Aguirre CG; Geronimo-Olvera C; Shah S; Rose J; Gerencser AA; Mak SK; Ehrlich ME; Bragg DC; Schilling B; Ellerby LM
    Neurobiol Dis; 2024 Jan; 190():106367. PubMed ID: 38042508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-linked dystonia parkinsonism syndrome (XDP, lubag): disease-specific sequence change DSC3 in TAF1/DYT3 affects genes in vesicular transport and dopamine metabolism.
    Herzfeld T; Nolte D; Grznarova M; Hofmann A; Schultze JL; Müller U
    Hum Mol Genet; 2013 Mar; 22(5):941-51. PubMed ID: 23184149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B.
    Vaine CA; Shin D; Liu C; Hendriks WT; Dhakal J; Shin K; Sharma N; Bragg DC
    Neurobiol Dis; 2017 Apr; 100():108-118. PubMed ID: 28017799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic SREK1 decrease in Huntington's disease lowers TAF1 mimicking X-linked dystonia parkinsonism.
    Hernández IH; Cabrera JR; Santos-Galindo M; Sánchez-Martín M; Domínguez V; García-Escudero R; Pérez-Álvarez MJ; Pintado B; Lucas JJ
    Brain; 2020 Jul; 143(7):2207-2219. PubMed ID: 32533168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAF1 Transcripts and Neurofilament Light Chain as Biomarkers for X-linked Dystonia-Parkinsonism.
    Al Ali J; Vaine CA; Shah S; Campion L; Hakoum A; Supnet ML; Acuña P; Aldykiewicz G; Multhaupt-Buell T; Ganza NGM; Lagarde JBB; De Guzman JK; Go C; Currall B; Trombetta B; Webb PK; Talkowski M; Arnold SE; Cheah PS; Ito N; Sharma N; Bragg DC; Ozelius L; Breakefield XO
    Mov Disord; 2021 Jan; 36(1):206-215. PubMed ID: 32975318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of Mosaic Divergent Repeat Interruptions in X-Linked Dystonia-Parkinsonism.
    Laß J; Lüth T; Schlüter K; Schaake S; Laabs BH; Much C; Jamora RD; Rosales RL; Saranza G; Diesta CCE; Pearson CE; König IR; Brüggemann N; Klein C; Westenberger A; Trinh J
    Mov Disord; 2024 Jul; 39(7):1145-1153. PubMed ID: 38616406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in TAF1 expression in female carrier induced pluripotent stem cells and human brain ontogeny has implications for adult neostriatum vulnerability in X-linked Dystonia Parkinsonism.
    D'Ignazio L; Jacomini RS; Qamar B; Benjamin KJM; Arora R; Sawada T; Evans TA; Diffenderfer KE; Pankonin AR; Hendriks WT; Hyde TM; Kleinman JE; Weinberger DR; Bragg DC; Paquola ACM; Erwin JA
    eNeuro; 2022 Jul; 9(4):. PubMed ID: 35868859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.